KCM
ABBV icon

KRS Capital Management’s AbbVie ABBV Stock Holding History

KRS Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.25M Buy
8,586
+14
+0.2% +$3.59K 1% 16
2026
Q2 		$2.16M Buy
8,572
+219
+3% +$47.1K 1% 18
2026
Q1 		$1.82M Buy
8,353
+3
+0% +$665 1.11% 14
2025
Q4 		$1.91M Buy
8,350
+3
+0% +$683 1.1% 17
2025
Q3 		$1.93M Sell
8,347
-26
-0.3% -$5.3K 1.17% 15
2025
Q2 		$1.55M Buy
8,373
+40
+0.5% +$7.43K 1.04% 19
2025
Q1 		$1.75M Sell
8,333
-26
-0.3% -$5.05K 1.39% 11
2024
Q4 		$1.49M Buy
8,359
+31
+0.4% +$5.7K 1.05% 19
2024
Q3 		$1.64M Sell
8,328
-453
-5% -$84.5K 1.2% 14
2024
Q2 		$1.51M Sell
8,781
-223
-2% -$36.9K 1.13% 16
2024
Q1 		$1.64M Sell
9,004
-690
-7% -$119K 1.32% 13
2023
Q4 		$1.5M Sell
9,694
-260
-3% -$37.9K 1.4% 13
2023
Q3 		$1.48M Buy
9,954
+284
+3% +$41.7K 1.58% 11
2023
Q2 		$1.3M Buy
9,670
+25
+0.3% +$3.67K 1.3% 13
2023
Q1 		$1.54M Buy
9,645
+74
+0.8% +$11.3K 1.73% 8
2022
Q4 		$1.55M Buy
9,571
+24
+0.3% +$3.68K 2.11% 6
2022
Q3 		$1.28M Buy
9,547
+47
+0.5% +$6.74K 1.77% 8
2022
Q2 		$1.46M Sell
9,500
-26
-0.3% -$3.97K 2.07% 5
2022
Q1 		$1.54M Buy
9,526
+22
+0.2% +$3.2K 1.67% 9
2021
Q4 		$1.29M Buy
+9,504
New +$1.12M 1.1% 17

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

KRS Capital Management's ABBV Position: Q3 2026 in Review

KRS Capital Management increased its AbbVie (ABBV) stake by 0.16% in Q3 2026, buying an estimated $3.59K and bringing the position to 8,586 shares worth $2.25M. The position accounts for 1% of the portfolio, ranked #16.

KRS Capital Management first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • KRS Capital Management held 8,586 shares of AbbVie worth $2.25M as of Q3 2026.
  • KRS Capital Management bought 14 AbbVie shares in Q3 2026, an estimated $3.59K.
  • AbbVie made up 1% of KRS Capital Management's portfolio in Q3 2026, its #16 holding.
  • KRS Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on KRS Capital Management's 13F filing for Q3 2026, filed 16 Oct 2026.